Who MEDVi is best for Not every platform is right for every patient
At Kureshi Weight Loss & Medspa, we understand that managing chronic conditions such as type 2 diabetes and weight-related concerns can be challenging, and part of that challenge might be understanding and managing medication costs
Individualized Care We prioritize a care strategy tailored specifically to your health needs and goals
We dont make direct comparisons between compounded and name-brand products, and we always help patients understand their options before prescribing anything
The systems that matter most for dementia prevention In longevity medicine, the practical question is not whether one therapy is good for the brain. The better question is whether the persons overall biology is moving toward resilience or vulnerability
Cardiolipin binding mechanism research FDA-approved for Barth syndrome (Forzinity) Mitochondrial membrane stabilization studies Ongoing clinical trials in heart failure and myopathy For mitochondrial peptide studies centered on cardiolipin stabilization, see our Elamipretide FDA approval status guide for a clearer look at the compound's regulatory history and current clinical positioning
